Compare DBL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DBL | SENS |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.6M | 308.5M |
| IPO Year | N/A | 2014 |
| Metric | DBL | SENS |
|---|---|---|
| Price | $14.57 | $5.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 72.2K | ★ 484.9K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | ★ 8.67% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $14.46 | $0.41 |
| 52 Week High | $16.01 | $8.75 |
| Indicator | DBL | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | 28.89 |
| Support Level | N/A | $5.46 |
| Resistance Level | $15.56 | $8.55 |
| Average True Range (ATR) | 0.09 | 0.50 |
| MACD | -0.03 | -0.27 |
| Stochastic Oscillator | 18.63 | 10.15 |
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.